News 29 jan 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 30 abr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
성공 사례 02 mai 2024 BeiGene이 전 세계 암 치료 접근성을 향상하는 방법 BeiGene은 스위스 바젤에 있는 유럽 본사에서 종양학 연구 및 개발을 발전시키고자 전 세계의 이해관계자와 전략적으로 협력합니다. 40개국에 제품을 시판하고 있으며 45개국 이상에서 임상시험을 ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 04 abr 2024 Indivi joins forces with Biogen Indivi and Biogen are cooperating on the development of digital biomarkers for Parkinson’s disease. To this end, the US biotech group is licensin...
Actualités 30 abr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 27 mar 2024 TissueLabs begins biofabrication activities in Bellinzona TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh ...
Aktuell 04 abr 2024 Indivi spannt mit Biogen zusammen Indivi und Biogen wollen bei der Entwicklung digitaler Biomarker für die Parkinson-Krankheit kooperieren. Dafür lizenziert der amerikanische Biot...
News 26 mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 26 jun 2023 Revolutionary mRNA vaccine against melanoma to be tested in Geneva Moderna's mRNA vaccine for melanoma will be tested at the Geneva University Hospitals in 2023. The vaccine, combined with immunotherapy, could si...
Aktuell 27 mar 2024 TissueLabs startet Biofabrikation in Bellinzona TissueLabs sichert sich 800'000 Dollar und eröffnet ein neues Zentrum für Biofabrikation in Bellinzona. Die Mittel dienen der Verbesserung der ei...
Exemples de Réussite 02 mai 2024 Comment BeiGene favorise l’accès au traitement du cancer à l’échelle mondiale Depuis son siège européen à Bâle, en Suisse, BeiGene collabore de manière stratégique avec des parties prenantes dans le monde entier pour f...
Success stories 02 mai 2024 BeiGene promuove l’accesso globale ai trattamenti antitumorali: ecco come Dalla sede europea di Basilea, in Svizzera, BeiGene collabora strategicamente con stakeholder in tutto il mondo per far progredire la ricerc...
News 12 mar 2024 Chemspeed acquired by Bruker Chemspeed Technologies is to be integrated in Bruker, the US manufacturer of instruments used in life sciences research. The specialist for autom...
News 03 abr 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
News 15 mai 2023 Revolutionizing pregnancy and birth monitoring: CSEM and University Hospital of Bern introduce automated solutions In a collaborative effort, CSEM and the Women’s Clinic of the University Hospital of Bern (Inselspital) have taken the lead in streamlining prena...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Aktuell 03 abr 2024 Nouscom erhält weitere Mittel für Krebsimpfstoffe Nouscom hat eine Investition in der Höhe von 7 Millionen Euro von der italienischen Risikokapitalfirma Angelini Ventures erhalten. Damit kann das...